P3 Health Partners PIII

P3 Health Partners reports $15.62 million net income for Q3 2026

P3 Health Partners (PIII) filed a 10-Q with the SEC on Nov 9, 2026, 4:46 pm ET. Source: the filing on SEC EDGAR.

Form
10-Q
Filed
Importance
Notable
  1. Revenue of $396.34 million for the three months ended Sep 30, 2026
  2. Net income of $15.62 million for the three months ended Sep 30, 2026
  3. Diluted EPS of $0.07 for the three months ended Sep 30, 2026
  4. Cash and equivalents of $43.9 million as of Sep 30, 2026

Written from the 10-Q on EDGAR. AI can make mistakes. Check the filing.

Going-concern warning repeated

“As a result of these matters, substantial doubt exists about the Company's ability to continue as a going concern for one year after the date the financial statements are issued.”
In the notes to the financial statements. Read it in the filing 10-Q on EDGAR

Also in the prior 10-Q (filed Aug 10, 2026). Prior report Prior on EDGAR

Quoted from the filing.

Get an email when P3 Health Partners files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

What changed since last quarter

No new risk factors or legal mentions.

Compared with the 10-Q for the period ended Jun 30, 2026.

Key numbers from the XBRL in this filing and the previous one.
This filingPreviousChange vs prior 10-Q
Revenue$396.34M$386.38M+2.6%
Operating income and margin$22.98M · 5.8%$41.23M · 10.7%−44%, margin −4.9 pts
Net income$15.62M$7.44M+110%
Operating cash flow−$685K−$61.91M+99%
Cash$43.9M$21.27M+106%

Data on this page was fetched . The filing on SEC.gov is the record.